
Applied AI Leader | Specialising
in Deep Learning, Multi-Omics &
Precision Medicine
Currently:
Senior Advisor, Agentic AI Strategy at AstraZeneca
Previously:
Head of AI at Flagship’s Quotient
Therapeutics &
Director of Data Science
at AstraZeneca
Highlighted Publications
- Disease prediction with multi-omics and biomarkers empowers case–control genetic discoveries in the UK Biobank
M Garg, M Karpinski, [13 authors], RS Dhindsa, S Petrovski, D Vitsios
Nature Genetics 56, 1821–1831, (2024) - Phenome-wide identification of therapeutic genetic targets, leveraging knowledge graphs, graph neural networks, and UK Biobank data
L Middleton, I Melas, C Vasavda, [9 authors], D Vitsios
Science Advances 10 (19), eadj1424 (2024) - Rare variant associations with plasma protein levels in the UK Biobank
RS Dhindsa, [16 authors], B Challis, A Platt, D Vitsios, EA Ashley, CD Whelan, MN Pangalos, Q Wang, S Petrovski
Nature 622, 339–347 (2023) - Applying Machine Learning on UK Biobank biomarker data empowers case-control discovery yield
M Garg, M Karpinski, D Matelska, L Middleton, J Mitchell, A O’Neill, Q Wang, AR Harper, RS Dhindsa, S Petrovski, D Vitsios
medRxiv 10.23296832 (2023) - Effects of protein-coding variants on blood metabolite measurements and clinical biomarkers in the UK Biobank
A Nag, RS Dhindsa, L Middleton, X Jiang, D Vitsios, [10 authors], S Petrovski
The American Journal of Human Genetics 110 (3), 487-498 (2023) - Cancer-driving mutations are enriched in genic regions intolerant to germline variation
D Vitsios, RS Dhindsa, D Matelska, J Mitchell, X Zou, J Armenia, F Hu, Q Wang, B Sidders, AR Harper, S Petrovski
Science Advances 8 (34), eabo6371 (2022) - DrugnomeAI: An ensemble machine-learning framework for predicting druggability of candidate drug targets
A Raies, E Tulodziecka, J Stainer, L Middleton, R Dhindsa, P Hill, O Engkvist, A Harper, S Petrovski, D Vitsios
Communications Biology 5 (1), 1291 (2022) - Human genetic evidence supports MAP3K15 inhibition as a therapeutic strategy for diabetes
A Nag, R Dhindsa, AR Harper, D Vitsios, [13 authors], MN Pangalos, S Petrovski
Science Advances 8 (46), eadd5430 (2022) - A minimal role for synonymous variation in human disease
RS Dhindsa, Q Wang, D Vitsios, OS Burren, F Hu, JE DiCarlo, L Kruglyak, DG MacArthur, ME Hurles, S Petrovski
The American Journal of Human Genetics 109 (12), 2105-2109 (2022) - Gene-SCOUT: identifying genes with similar continuous trait fingerprints from phenome-wide association analyses
L Middleton, AR Harper, A Nag, Q Wang, A Reznichenko, D Vitsios*, S Petrovski*
Nucleic Acids Research https://doi.org/10.1093/nar/gkac274 (2022) - Rare variant contribution to human disease in 281,104 UK Biobank exomes
Q Wang, [5 authors], D Vitsios, [11 authors], S Petrovski
Nature 597 (7877), 527-532 (2021) - Prioritizing non-coding regions based on human genomic constraint and sequence context with deep learning
D Vitsios, R Dhindsa, L Middleton, A Gussow, S Petrovski
Nature Communications 12 (1), 1-14 (2021) - Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis
R Dhindsa, [7 authors], D Vitsios, [18 authors], S Petrovski
Communications Biology 4 (1), 1-8 (2021) - Mantis-ml: Disease-Agnostic Gene Prioritization from High-Throughput Genomic Screens by Stochastic Semi-supervised Learning
D Vitsios, S Petrovski
The American Journal of Human Genetics 106 (5), 659-678 (2020) - Exome-based rare-variant analyses in chronic kidney disease
SC Christie, [3 authors], D Vitsios, [15 authors], A Gharavi
Journal of the American Society of Nephrology 30 (6), 1109-1122 (2019) - A programmed wave of uridylation-primed mRNA degradation is essential for meiotic progression and mammalian spermatogenesis
M Morgan, [6 authors], D Vitsios, [6 authors], Donal O’Carroll
Cell Research https://doi.org/10.1038/s41422-018-0128-1 (2019) - Mirnovo: genome-free prediction of microRNAs from small RNA sequencing data and single-cells using decision forests
DM Vitsios, E Kentepozidou, L Quintais, E Benito-Gutiérrez, …
Nucleic Acids Research 45 (21), e177-e177 6 (2017) - mRNA 3’uridylation and poly (A) tail length sculpt the mammalian maternal transcriptome.
M Morgan, C Much, M DiGiacomo, C Azzi, I Ivanova, DM Vitsios, J Pistolic, …
Nature 548 (7667), 347-351 24 (2017) - A MILI-independent piRNA biogenesis pathway empowers partial germline reprogramming
L Vasiliauskaitė, D Vitsios, RV Berrens, C Carrieri, W Reik, AJ Enright, …
Nature Structural & Molecular Biology 24 (7), 604 5 (2017) - BioPAXViz: a cytoscape application for the visual exploration of metabolic pathway evolution
FE Psomopoulos*, DM Vitsios*, S Baichoo, CA Ouzounis
Bioinformatics 33 (9), 1418-1420 4 (2017) - In situ functional dissection of RNA cis-regulatory elements by multiplex CRISPR-Cas9 genome engineering
Q Wu, QRV Ferry, TA Baeumler, YS Michaels, DM Vitsios, O Habib, …
Nature Communications 8 (1), 2109 3 (2017) - Large-scale analysis of microRNA expression, epi-transcriptomic features and biogenesis
DM Vitsios, MP Davis, S van Dongen, AJ Enright
Nucleic Acids Research 45 (3), 1079-1090 21 (2016) - Chimira: analysis of small RNA sequencing data and microRNA modifications
DM Vitsios, AJ Enright
Bioinformatics 31 (20), 3365-3367 34 (2015)
PhD Thesis
D Vitsios, University of Cambridge, 2017
orcid.org/0000-0002-8939-5445